Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.8M Sell
23,008
-682
-3% -$1.09M 2.89% 9
2026
Q1
$31.3M Sell
23,690
-386
-2% -$529K 2.25% 16
2025
Q4
$25.8M Buy
24,076
+97
+0.4% +$101K 1.87% 23
2025
Q3
$23.2M Buy
23,979
+1,478
+7% +$1.16M 1.74% 24
2025
Q2
$18M Buy
22,501
+2,344
+12% +$1.68M 1.47% 26
2025
Q1
$13.4M Buy
20,157
+4,573
+29% +$3.33M 1.15% 32
2024
Q4
$10.8M Buy
15,584
+21
+0.1% +$15.1K 0.93% 39
2024
Q3
$13M Buy
15,563
+1,368
+10% +$1.22M 1.13% 34
2024
Q2
$14.5M Buy
14,195
+1,564
+12% +$1.5M 1.34% 32
2024
Q1
$12.3M Buy
12,631
+734
+6% +$651K 1.19% 33
2023
Q4
$9M Buy
11,897
+1,112
+10% +$734K 0.94% 35
2023
Q3
$6.35M Buy
+10,785
New +$7.16M 0.76% 36

Other funds holding ASML

Blue Chip Partners's ASML Position: Q2 2026 in Review

Blue Chip Partners reduced its ASML (ASML) stake by 2.9% in Q2 2026, selling an estimated $1.09M and leaving 23,008 shares worth $45.8M. The position accounts for 2.89% of the portfolio, ranked #9.

Blue Chip Partners first reported a position in ASML in Q3 2023 and has held it in 12 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Blue Chip Partners held 23,008 shares of ASML worth $45.8M as of Q2 2026.
  • Blue Chip Partners sold 682 ASML shares in Q2 2026, an estimated $1.09M.
  • ASML made up 2.89% of Blue Chip Partners's portfolio in Q2 2026, its #9 holding.
  • Blue Chip Partners first reported a position in ASML in Q3 2023 and has held it in 12 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Blue Chip Partners's 13F filing for Q2 2026, filed 14 Aug 2026.